New approaches in the management of spasticity in multiple sclerosis patients: role of cannabinoids
Paul F SmithDepartment of Pharmacology and Toxicology, School of Medical Sciences, University of Otago, Dunedin, New ZealandAbstract: Cannabinoids such as Cannabis-based medicinal extracts (CBMEs) are increasingly being used in the treatment of spasticity associated with multiple sclerosis (MS). The...
Saved in:
Main Author: | Paul F Smith (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2010-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Exploring the efficacy of cannabinoids in the management of multiple sclerosis
by: Aleksandra Rykucka, et al.
Published: (2024) -
Unveiling the Potential of Cannabinoids in Multiple Sclerosis and the Dawn of Nano-Cannabinoid Medicine
by: Roua A. Nouh, et al.
Published: (2024) -
The coexistence of multiple sclerosis and hereditary spastic paraparesis in a patient
by: Işıl Yazıcı, et al.
Published: (2013) -
New approaches in the management of multiple sclerosis
by: Laurie J Barten, et al.
Published: (2010) -
The protective effects of lavender herbal tea on spasticity and ataxia in patients with multiple sclerosis
by: Nahid Jivad, et al.
Published: (2023)